Burkitts Lymphoma - A TMH experience at XXXVI Annual Conference of ISHBT (Indian Society of Haematology and Blood Transfusion) 1995, Bangalore.
CNS directed chemotherapy in children less than or equal to 3 years of age: Use of G-CSF in maintaining dose intensity- in Feb 1997 at Madurai in ISMPO (Indian Society of Medical and Paediatric Oncology).
Low incidence of cardio toxicity following daunomycin and doxorubicin at a 10 year follow-up in March 1997 at Annual Conference of Bombay Haematology group at Bombay
Single centre evaluation of long term follow up of autologous stem cell transplantation for first remission adult ALL: potential for cure without excessive toxicity; Annual meeting of European Bone Marrow Transplantation (EBMT) Group, Innsbruck 6th March 2000.
Central nervous system relapse after stem cell transplantation (SCT) for acute leukaemia beyond first remission; Annual meeting of EBMT Group, Innsbruck 6th March 2000.
CNS relapse after auto- and allo- stem cell transplant (SCT) for acute leukaemia beyond first CR. 5th Annual Meeting of the European Haematology Association, June 2000.
High-dose mephalan with auto-transplantation in Myeloma patients with severe renal dysfunction (GFR
<20 ML/MIN/Ms): High incidence of atrial fibrillation and treatment related mortality. 6th Congress of European Haematology Association (EHA) Frankfurt, 24 June 2001
Second high-dose melphalan autografts for myeloma patients relapsing after one autograft: results equivalent to tandem transplantation. 28th EBMT Annual Meeting, Montreux, Switzerland, 25th March 2002
Bone marrow or peripheral blood stem cell auto transplantation (PBSCT) for acute myeloid leukaemia in first remission? A matched-pair analysis from the Royal Marsden Hospital and the European Blood and Marrow Transplant group (EBMT). 28th EBMT Annual Meeting, Montreux, Switzerland. 27th March 2002
Salvage autografts for myeloma patients relapsing after one autograft: results equivalent to tandem transplantation. Annual Scientific Meeting of the British Society for Haematology, Brighton, UK. 16th April 2002.
Single centre results of 200mg/m2 melphalan (HDM200) and autograft (tx) in 451 myeloma patients: identifying patients with prolonged survival based upon albumin and 2Microglobulin at transplant at American society of clinical Oncology, Orlando, 20th May 2002
Outcome of auto transplantation in 118 adult acute myeloid leukaemia patients in first complete remission: impact of consolidation chemotherapy: 7th Congress of European Haematology Association (EHA), Florence, and Itlay.9th June 2002.
High-dose melphalan and second autografts for myeloma relapsing after one autograft: results equivalent to tandem auto transplantation. 7th Congress of EHA, Florence, Italy, 7th June 2002.
Long-Term Outcome of Myeloma Patients Treated with an Elective Single Autograft with Follow-up (5 Years): Results Comparable to Tandem Auto transplantation, American society of Haematology, Philadelphia, and 9th Dec 2002.
Prognostic Factors at the Time of Single Auto transplantation in 451 Myeloma Patients treated with 200 mg/m2 Melphalan: Results Equivalent to Tandem Auto transplantation, American society of Haematology, Philadelphia, and 9th December 2002.
Auto transplantation in Myeloma: Prognostic factors, 29th EBMT Annual Meeting, Istanbul, Turkey, 21st July 2003
Prognostic factors at the time of auto transplantation in myeloma, 8th Congress of EHA, Lyons, France 14th June 2003
Results of randomised, cross over study comparing pegylated interferon with interferon-alpha2b in patients with myeloma, 8th Congress of EHA, Lyons, France 15th June 2003
Serum free light chain assessment in myeloma patients in complete remission, 29th EBMT Annual Meeting, Istanbul, Turkey, 21st July 2003
Randomised, two-period cross over study comparing quality of life and toxicity of pegylated interferon with interferon-alpha2b in patients with myeloma, 29th EBMT Annual Meeting, Istanbul, Turkey, 22nd July 2003.
Effect of human growth hormone in haemato-oncology patients receiving intensive chemotherapy- a double blind randomised placebo controlled trial, 23rd joint meeting of British Endocrine societies, Brighton, 23rd March 2004.
Long term use of Capecitabine in patients with locally recurrent or metastatic breast cancer: concept for metronomic chemotherapy, ESMO Lugano 2008